Company Filing History:
Years Active: 2018
Introduction
Na Youn Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compositions that target immune responses.
Latest Patents
Na Youn Kim holds one patent titled "Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells." This innovation revolves around the medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine. The pharmaceutical composition described in the patent is designed to inhibit immune responses and facilitate the differentiation of undifferentiated T cells into regulator T cells.
Career Highlights
Currently, Na Youn Kim is employed at LG Chem, Ltd., where he continues to work on cutting-edge pharmaceutical innovations. His expertise in immune modulation positions him as a key player in advancing therapeutic solutions.
Collaborations
Throughout his career, Na Youn Kim has collaborated with talented colleagues such as Seok Goo Cho and Eun Jung Kim. Together, they work on groundbreaking research aimed at improving health outcomes through innovative pharmaceutical solutions.
Conclusion
In summary, Na Youn Kim's inventive contributions to the pharmaceutical industry highlight his dedication to advancing medical science. His patent showcases a unique approach to managing immune responses, underscoring the potential impact of his work on patient care. With ongoing collaborations and a strong professional base at LG Chem, Ltd., Kim continues to be an influential figure in his field.